271 related articles for article (PubMed ID: 29900128)
1. Residual Peripheral Blood CD26
Bocchia M; Sicuranza A; Abruzzese E; Iurlo A; Sirianni S; Gozzini A; Galimberti S; Aprile L; Martino B; Pregno P; Sorà F; Alunni G; Fava C; Castagnetti F; Puccetti L; Breccia M; Cattaneo D; Defina M; Mulas O; Baratè C; Caocci G; Sica S; Gozzetti A; Luciano L; Crugnola M; Annunziata M; Tiribelli M; Pacelli P; Ferrigno I; Usala E; Sgherza N; Rosti G; Bosi A; Raspadori D
Front Oncol; 2018; 8():194. PubMed ID: 29900128
[TBL] [Abstract][Full Text] [Related]
2. Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26
Pacelli P; Santoni A; Sicuranza A; Abruzzese E; Giai V; Crugnola M; Annunziata M; Galimberti S; Iurlo A; Luciano L; Sorà F; Fava C; Bestoso E; Marzano C; Cartocci A; Defina M; Sammartano V; Cencini E; Raspadori D; Bocchia M
Front Pharmacol; 2023; 14():1194712. PubMed ID: 37305536
[No Abstract] [Full Text] [Related]
3. Flow Cytometry Assessment of CD26
Raspadori D; Pacelli P; Sicuranza A; Abruzzese E; Iurlo A; Cattaneo D; Gozzini A; Galimberti S; Baratè C; Pregno P; Nicolosi M; Sorà F; Annunziata M; Luciano L; Caocci G; Moretti S; Sgherza N; Fozza C; Russo S; Usala E; Liberati MA; Ciofini S; Trawinska MM; Gozzetti A; Bocchia M
Cytometry B Clin Cytom; 2019 Jul; 96(4):294-299. PubMed ID: 30714299
[TBL] [Abstract][Full Text] [Related]
4. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
Abruzzese E; Bocchia M; Trawinska MM; Raspadori D; Bondanini F; Sicuranza A; Pacelli P; Re F; Cavalleri A; Farina M; Malagola M; Russo D; De Fabritiis P; Bernardi S
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627140
[TBL] [Abstract][Full Text] [Related]
5. Leukemic stem cells shall be searched in the bone marrow before "tyrosine kinase inhibitor-discontinuation" in chronic myeloid leukemia.
Ilhan O; Narli Ozdemir Z; Dalva K; Arslan A; Okay Ozgeyik M; Ipek S; Saydam G; Haznedaroglu IC
Int J Lab Hematol; 2021 Oct; 43(5):1110-1116. PubMed ID: 33834631
[TBL] [Abstract][Full Text] [Related]
6. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia.
Sharma P; Sachdeva MUS; Naseem S; Sreedharanunni S; Das R; Malhotra P; Varma N
Int J Lab Hematol; 2022 Jun; 44(3):518-523. PubMed ID: 35142061
[TBL] [Abstract][Full Text] [Related]
7. CD26/DPP-4 in Chronic Myeloid Leukemia.
Sicuranza A; Raspadori D; Bocchia M
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205639
[TBL] [Abstract][Full Text] [Related]
8. CD26 expression on circulating CD34+/CD38- progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia-A single-center validation study.
Rahman K; Singh MK; Chandra D; Gupta R; Sarkar MK; Gupta P; Gupta A; Yadav S; Kashyap R; Nityanand S
Int J Lab Hematol; 2022 Jun; 44(3):524-530. PubMed ID: 35315228
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia.
Ebian HF; Abdelnabi AM; Abdelazem AS; Khamis T; Fawzy HM; Hussein S
Leuk Res Rep; 2022; 17():100321. PubMed ID: 35602932
[TBL] [Abstract][Full Text] [Related]
10. miRNome profiling of LSC-enriched CD34
Ruiz MS; Sánchez MB; Bonecker S; Furtado C; Koile D; Yankilevich P; Cranco S; Custidiano MDR; Freitas J; Moiraghi B; Pérez MA; Pavlovsky C; Varela AI; Ventriglia V; Sánchez Ávalos JC; Larripa I; Zalcberg I; Mordoh J; Valent P; Bianchini M
Front Pharmacol; 2020; 11():612573. PubMed ID: 33569005
[TBL] [Abstract][Full Text] [Related]
11. Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia.
Kana S; John S; Basu D; Kar R; Nachiappa Ganesh R; Dubashi B
Cureus; 2024 Mar; 16(3):e56944. PubMed ID: 38665755
[TBL] [Abstract][Full Text] [Related]
12. Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.
Chomel JC; Bonnet ML; Sorel N; Sloma I; Bennaceur-Griscelli A; Rea D; Legros L; Marfaing-Koka A; Bourhis JH; Ame S; Guerci-Bresler A; Rousselot P; Turhan AG
Oncotarget; 2016 Jun; 7(23):35293-301. PubMed ID: 27167108
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chronic myeloid leukemia stem cells and hematopoietic stem cells by global proteomic analysis.
Zhou S; Zhu X; Liu W; Cheng F; Zou P; You Y; Xiao Y; Guo A; Zhu X
Biochem Biophys Res Commun; 2020 Feb; 522(2):362-367. PubMed ID: 31767149
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood quantitation of CD26 positive leukemic stem cells as a predictor of tyrosine kinase inhibitor response in chronic myeloid leukemia.
Chaudhary N; Rahman K; Gupta P; Gupta R; Sarkar MK; Singh MK; Chandra D; Kumar S; Kashyap R
Int J Lab Hematol; 2024 May; ():. PubMed ID: 38711332
[TBL] [Abstract][Full Text] [Related]
15. The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.
Galimberti S; Grassi S; Baratè C; Guerrini F; Ciabatti E; Perutelli F; Ricci F; Del Genio G; Montali M; Barachini S; Giuliani C; Ferreri MI; Valetto A; Abruzzese E; Ippolito C; Iurlo A; Bocchia M; Sicuranza A; Martino B; Iovino L; Buda G; Salehzadeh S; Petrini M; Di Paolo A; Mattii L
Front Oncol; 2018; 8():555. PubMed ID: 30574454
[TBL] [Abstract][Full Text] [Related]
16. Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
Houshmand M; Garello F; Stefania R; Gaidano V; Cignetti A; Spinelli M; Fava C; Nikougoftar Zarif M; Galimberti S; Pungolino E; Annunziata M; Luciano L; Specchia G; Bocchia M; Binotto G; Bonifacio M; Martino B; Pregno P; Stagno F; Iurlo A; Russo S; Aime S; Circosta P; Saglio G
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804056
[TBL] [Abstract][Full Text] [Related]
17. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.
Alikian M; Gale RP; Apperley JF; Foroni L
Biomol Detect Quantif; 2017 Mar; 11():4-20. PubMed ID: 28331814
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation.
Jiang L; Wang H; Zhu X; Liu W; Zhou S; Geng Z; Xiao Y; Zou P; You Y; Li Q; Zhu X
Stem Cells Dev; 2019 Nov; 28(22):1480-1485. PubMed ID: 31530245
[TBL] [Abstract][Full Text] [Related]
19. Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia.
Ito K; Ito K
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830976
[TBL] [Abstract][Full Text] [Related]
20. Phenotyping and Target Expression Profiling of CD34
Blatt K; Menzl I; Eisenwort G; Cerny-Reiterer S; Herrmann H; Herndlhofer S; Stefanzl G; Sadovnik I; Berger D; Keller A; Hauswirth A; Hoermann G; Willmann M; Rülicke T; Sill H; Sperr WR; Mannhalter C; Melo JV; Jäger U; Sexl V; Valent P
Neoplasia; 2018 Jun; 20(6):632-642. PubMed ID: 29772458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]